Drugs / Duspatalin
last change Mar 2023 re-read 2 minutes ago

Duspatalin

Developed for
irritable bowel syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05815602 Comparator Mar 2023 → Oct 2027 expected irritable bowel syndrome Guy Boeckxstaens Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Duspatalin ClinicalTrials.gov intervention name — accepted as the source's own label NCT05815602